Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.
Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss pharmaceutical firm signed an exclusive agreement with Zealand Pharma to produce ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.
18h
Zacks.com on MSNVKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug SupplyThe deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its ...
Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...
The makers of weight-loss drugs Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.
12h
Medical Device Network on MSNVivani Medical to spin-off neurostim business Cortigent as public companyVivani was created in 2022 when subdermal drug implant company Nano Precision Medical merged with implantable visual prosthetics company Second Sight Medical Products. The new com ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...
The one-year increase was the second highest since the state established its benchmark to rein in expenditures in 2013.
The Copenhagen municipality has released what the proposal for a new bridge to be built between Enghave Brygge and Islands Brygge would look like. The Technology and Environmental Administration have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results